29 January 2020 - The White House Council of Economic Advisors just issued a damning indictment of a House bill (H.R. 3) designed to lower drug prices. 

According to White House economists, the measure endorsed by Nancy Pelosi and her fellow House Democrats could prevent the development of 100 new drugs over the next ten years. CEA concluded "the threat [the bill] poses to continued medical innovation will harm American patients in ways that far outweigh any benefits."

This analysis is spot-on.

Read Forbes article